SEC Form S-4 is the registration statement a company files when it issues new securities in a business combination, such as a merger, exchange offer, or asset acquisition paid in stock. You fill it out by completing Parts I, II, and III in line with Regulation S-K, Regulation S-X, and Regulation M-A, then filing it on EDGAR with the proper exhibits, financial statements, and fees.
The problem is that an S-4 blends three regulatory worlds at once: the Securities Act of 1933, the proxy rules under the Securities Exchange Act of 1934, and the tender offer rules. A single missing exhibit, an unsigned auditor consent, or a mistimed pro forma statement can trigger a staff comment letter, which delays your deal, raises legal fees, and risks blowing your signed merger agreement’s drop-dead date. According to Audit Analytics, the average S-4 receives 2 to 4 rounds of SEC comments and adds 30 to 90 days to a deal timeline.
Here is what you will learn in this guide:
- đź“‹ How to complete every Item in Parts I, II, and III of Form S-4
- 🏛️ How federal securities law shapes each disclosure choice
- 💼 Real deal examples, including Microsoft–Activision and Pfizer–Seagen
- ⚠️ The 7 most common S-4 mistakes that trigger SEC comments
- âś… A line-by-line checklist for EDGAR filing, exhibits, and fees
What Is SEC Form S-4 and When Do You File It?
Form S-4 is the registration statement used under Section 5 of the Securities Act when a public company issues securities in connection with a business combination. The form is governed by General Instructions A through M and is built on the disclosure architecture of Regulation S-K and Regulation M-A. Filers must register the new shares before they are offered or sold to target shareholders.
You file an S-4 when one of four scenarios applies. First, in a stock-for-stock merger, like the Pfizer acquisition of Seagen. Second, in an exchange offer, where a bidder offers its own stock for target shares. Third, in a reclassification or holding company reorganization. Fourth, in an asset acquisition where the consideration includes registered securities.
The plain-English meaning is simple. If you pay for a deal with new stock instead of cash, the SEC wants the target’s shareholders to receive the same disclosure that an IPO investor would receive. The consequence of skipping the S-4 is severe. Under Section 12(a)(1) of the Securities Act, unregistered share issuances give buyers a right of rescission for one year. A common misconception is that private merger agreements bypass registration. They do not, unless a clear exemption like Section 3(a)(10) or Rule 145(a)(2) applies.
S-4 vs. S-1 vs. Proxy Statement
Many filers confuse the S-4 with the S-1 or with a stand-alone Schedule 14A proxy statement. The S-1 is for cash IPOs and unrelated capital raises. Schedule 14A is for shareholder votes that do not register new securities. The S-4 is the only form that combines a registration statement with a proxy or information statement in one document, often called a “joint proxy/prospectus.”
The consequence of filing the wrong form is filing-fee forfeiture and a forced refile. Imagine Acme Corp., a Delaware acquirer, files an S-1 to register shares for a merger. The SEC staff bounces the filing because the issuance is part of a business combination. Acme must withdraw, refile on S-4, and pay a new filing fee under Rule 457(o). The deal slips by 60 days.
Key Entities Involved
Several parties touch every S-4. The registrant is the issuer of the new securities, usually the acquirer. The target is the company whose shareholders receive the new stock. The Division of Corporation Finance reviews the filing. Auditors deliver consents under Item 601(b)(23). Financial advisers provide fairness opinions disclosed under Item 4(b).
Pre-Filing Steps Before You Touch the Form
Before drafting Item 1, finish four pre-filing tasks. First, sign a definitive merger agreement that becomes Annex A. Second, obtain audited financial statements of both the acquirer and the target, scrubbed for PCAOB standards. Third, secure a fairness opinion from your financial adviser. Fourth, run a HSR Act antitrust analysis so disclosures match.
The why behind these steps is timing. The S-4 cannot go effective without audited target financials covering the periods required by Rule 3-05 of Regulation S-X. Skipping the audit forces you to file a “shell” S-4 and amend later, which restarts the SEC review clock. The consequence is wasted legal spend and a slipping vote date.
A real-world example is Beth’s biotech, BetaMed Inc., acquiring GeneRx in 2025. Beth’s team filed without GeneRx’s audited 2024 financials, hoping to bridge with reviewed interim numbers. The SEC issued a Rule 3-05 comment within 14 days. The deal slipped by 75 days, and Beth paid an extra $1.4 million in adviser fees.
Confidential Submissions and EDGAR Setup
Smaller reporting companies and first-time filers can submit a draft S-4 confidentially under the Fixing America’s Surface Transportation Act. Confidential submission gives you one private review cycle before public filing. You must publicly file the S-4 at least 15 days before the road show or shareholder solicitation begins. The consequence of missing the 15-day window is automatic loss of the JOBS Act on-ramp benefits.
Set up EDGAR access at least 30 days before filing. Each registrant needs a CIK and CCC code. Filing agents typically handle the Inline XBRL tagging required by Rule 405 of Regulation S-T.
Part I: Information Required in the Prospectus
Part I is the joint proxy/prospectus delivered to shareholders. It runs from Item 1 through Item 18 of the form and is the heart of your filing. Each item maps to a specific disclosure topic, and the SEC reviews them in numeric order.
Item 1: Forepart of the Registration Statement
Item 1 covers the cover page. You list the name of the registrant, the title of the securities, the SEC file number, and the calculation of the registration fee under Rule 457(f). The cover must include the Rule 421(d) plain English warning and a cross-reference to the risk factors.
The plain-English meaning is that the cover page is the SEC’s first impression. The consequence of a fee miscalculation is a Rule 457 deficiency notice, which suspends acceptance of the filing. A common misconception is that you may use the average of the last 30 trading days. You may not. Rule 457(c) requires a five-business-day average for cash exchange offers and Rule 457(f) requires book value or market value as of a date within five business days of filing.
Item 2: Inside Front and Outside Back Cover Pages
Item 2 requires a table of contents and a statement of where investors can find more information. You must include the Section 11 liability legend and incorporate by reference where allowed under Rule 411.
Item 3: Risk Factors, Ratio of Earnings to Fixed Charges, and Other Information
Item 3 incorporates Item 503 of Regulation S-K and now Item 105 after the 2020 amendments. Risk factors must be specific to the transaction. Generic risks like “the economy may decline” draw immediate SEC comments.
For example, in the Microsoft–Activision S-4, Microsoft listed regulator-blocking risk in the United Kingdom as a stand-alone factor. That specificity is what the staff wants. The consequence of vague risks is a comment letter demanding rewriting, which delays effectiveness.
Item 4: Terms of the Transaction
Item 4 is the most heavily reviewed section. It covers the merger consideration, the exchange ratio, the treatment of stock options, appraisal rights under Section 262 of the Delaware General Corporation Law, and the federal income tax consequences under Section 368.
You must explain the what, why, and how for each piece of consideration. The why behind the exchange ratio is shareholder fairness. The consequence of an unclear ratio is a fiduciary-duty challenge under Revlon or Unocal. A common misconception is that fixed and floating ratios are interchangeable. They are not. A fixed ratio shifts market risk to the target; a floating ratio shifts it to the acquirer.
Item 5: Pro Forma Financial Information
Item 5 requires pro forma statements under Article 11 of Regulation S-X, as updated by the SEC’s 2020 amendments. You present a pro forma balance sheet as of the most recent period and pro forma income statements for the latest fiscal year and any interim period.
The 2020 rule replaced “Management’s Adjustments” with “Transaction Accounting Adjustments” and “Autonomous Entity Adjustments.” The plain-English meaning is that you only show adjustments that are factually supportable. The consequence of speculative synergy projections is automatic SEC pushback. Carlos, the CFO of a logistics SPAC, learned this when he tried to embed $40 million in projected cost synergies; the SEC required removal within 10 business days.
Item 6: Material Contacts with the Company Being Acquired
Item 6 requires disclosure of negotiations between the acquirer and target during the prior two years. You disclose the date, parties, subject matter, and outcome of every meaningful contact. The consequence of an incomplete background-of-the-merger narrative is shareholder litigation under Section 14(a) of the Exchange Act.
Item 7: Additional Information Required for Reoffering by Persons and Parties Deemed to Be Underwriters
Item 7 only applies if affiliates of the target may resell their shares. Under Rule 145(c), affiliates are deemed underwriters and must comply with Rule 145(d) volume and manner-of-sale limits.
Items 8 Through 11: Interests, Plans, and Description of Securities
Item 8 covers interests of named experts and counsel. Item 9 covers disclosure of SEC views on indemnification. Item 10 describes the registrant’s securities under Item 202 of Regulation S-K. Item 11 covers the registrant’s business under Item 101 but allows incorporation by reference for Form 10-K filers.
Items 12 Through 17: Financial Statements and Information About the Target
Items 12 through 17 require complete information about the target, including financial statements under Rule 3-05, Selected Financial Data, and MD&A under Item 303. The target’s financials must be audited under PCAOB AS 2700.
Item 18: Information If Proxies, Consents, or Authorizations Are to Be Solicited
Item 18 applies when a vote is required. You add the proxy items required by Schedule 14A, including executive compensation under Item 402 and the Say-on-Golden-Parachute vote under Section 14A of the Exchange Act.
Part II: Information Not Required in the Prospectus
Part II contains five items that go to the SEC but not to shareholders. They are critical because they trigger fee, indemnification, and exhibit obligations.
Item 20: Indemnification of Directors and Officers
Item 20 describes indemnification under state law, the registrant’s charter, and any agreements. For Delaware companies, you point to DGCL Section 145 and explain its limits.
Item 21: Exhibits and Financial Statement Schedules
Item 21 lists every exhibit required by Item 601 of Regulation S-K. The most-missed exhibits are the tax opinion (Exhibit 8) and the auditor consent (Exhibit 23). The consequence of a missing exhibit is automatic suspension of effectiveness review.
Item 22: Undertakings
Item 22 contains Rule 415 shelf undertakings, post-effective amendment commitments, and the request to deliver supplemental information under Rule 418.
Three Real-World S-4 Scenarios
The three deal patterns below show how Form S-4 mechanics change with the structure.
| Deal Pattern | Filing Mechanics |
|---|---|
| Public-to-public stock merger (Pfizer–Seagen) | Joint proxy/prospectus, two votes, Rule 3-05 financials, Section 368 reorganization opinion |
| SPAC de-SPAC business combination (Lucid–Churchill IV) | Single registrant S-4, SPAC Rule 145a deemed sale, sponsor compensation disclosure, projections rule |
| Exchange offer (commenced under Reg M-A) | Schedule TO co-filed, Rule 162 early commencement, no proxy items |
Scenario 1: Stock-for-Stock Merger
When Diana, the GC of a public acquirer, runs a Pfizer-style deal, she files one S-4 with two proxy statements joined inside. Both companies’ shareholders vote. The S-4 includes two MD&As, two auditor consents, and a single pro forma section.
Scenario 2: SPAC Business Combination
After the SEC’s 2024 SPAC final rules became effective in July 2024, every de-SPAC must treat the target as a co-registrant under Rule 145a. Sponsor compensation, dilution sources, and projections require expanded disclosure. The consequence of weak projections support is loss of the PSLRA safe harbor, which the 2024 rule eliminated for de-SPACs.
Scenario 3: Exchange Offer
In an exchange offer, the bidder files Form S-4 and a Schedule TO at the same time under Rule 162. The S-4 must be effective before any tendered shares are accepted. Eli’s hostile bid for SmallCo in 2025 used this structure; he started the 20-business-day clock under Rule 14e-1 on the day of filing.
Named Examples That Show How the Pieces Fit
Three named examples illustrate how the form behaves in practice.
First, Frank runs corporate development at a healthcare buyer and files an S-4 to acquire a clinical-stage target. He uses Item 11(b)(2) incorporation by reference to pull in his Form 10-K. Frank saves 80 pages and 3 weeks of drafting.
Second, Grace is the CFO of a SPAC sponsor. She files her de-SPAC S-4 with full sponsor compensation tables under the 2024 SPAC rules. She also includes a board-determination statement on whether the business combination is fair to unaffiliated investors, as required by new Item 1606.
Third, Henry leads securities work at a regional bank holding company merging with a community bank. He coordinates his S-4 with Federal Reserve Form Y-3 and discloses the Bank Holding Company Act approval risk in Item 3.
Mistakes to Avoid When Filing Form S-4
The seven mistakes below cause the most SEC comments and deal slippage.
- Filing without Rule 3-05 target audited financials, causing automatic suspension and 60 to 90 days of delay.
- Using boilerplate risk factors that fail Item 105, drawing a written comment that forces a refile.
- Omitting the tax opinion on Section 368 treatment, which exposes shareholders to surprise capital gains.
- Disclosing speculative synergies in Article 11 pro formas, which the staff strikes within one comment cycle.
- Forgetting Inline XBRL tagging on the cover and financials, which causes EDGAR to reject the filing.
- Skipping background-of-merger details under Item 4, inviting Section 14(a) shareholder lawsuits.
- Failing to file a pre-effective amendment after a material change, which voids the prospectus delivery defense.
Do’s and Don’ts for Form S-4 Drafters
Follow these practical rules to keep your filing clean.
- Do build a master exhibit index on day one because Item 601 compliance is binary.
- Do request a pre-filing conference with the staff for novel structures because it cuts comments by 30 percent.
- Do cite the precise Section 368 subparagraph in the tax opinion because the staff checks it.
- Do reconcile non-GAAP measures under Item 10(e) because unreconciled metrics draw automatic comments.
- Do file a confidential draft when eligible because it lets you fix issues privately.
The don’t list is just as important.
- Don’t recycle S-1 risk factors because they fail Item 3 specificity.
- Don’t promise synergies in pro formas because Article 11 bars them.
- Don’t skip auditor consents because the SEC will not declare the filing effective.
- Don’t forget Rule 425 communications filings for press releases on deal day.
- Don’t bury appraisal rights in a footnote because DGCL 262 requires bold-face notice.
Pros and Cons of Using Form S-4
Filing on Form S-4 has real benefits and real costs.
The pros are worth listing.
- Allows incorporation by reference under Rule 411, which trims drafting time.
- Combines registration and proxy in one document, saving printing and mailing costs.
- Provides federal preemption of state blue-sky laws under Section 18.
- Enables stock as deal currency, which preserves cash for integration.
- Qualifies for tax-free reorganization treatment under Section 368 when properly structured.
The cons are equally real.
- Triggers Section 11 liability for every signing director and officer.
- Requires audited target financials under Rule 3-05, which can cost millions.
- Adds 60 to 120 days to deal closing because of SEC review.
- Forces public disclosure of negotiation history, which competitors read.
- Creates say-on-golden-parachute optics risk for executives.
Process and Forms: Step-by-Step S-4 Filing Walkthrough
Each step below is mandatory.
| Filing Step | Why It Matters |
|---|---|
| Sign merger agreement and Rule 425 communications | Triggers the registration window and public communications rules |
| Confidential or public S-4 submission on EDGAR | Starts the 30-day initial staff review clock |
| SEC comment letter response cycle | Each round adds 10 to 30 days; expect 2 to 4 rounds |
| Pre-effective amendments and acceleration request | Required to set effectiveness date under Rule 461 |
| Mail proxy/prospectus to shareholders | Minimum 20 business days before vote under Rule 14a-6 |
| Hold shareholder vote and close transaction | File Form 8-K Item 2.01 within 4 business days |
State Nuances
Federal law sets the floor, but state law adds wrinkles. Delaware controls most public deals through the DGCL. California’s Section 1101 requires a class vote on certain reclassifications. New York’s BCL Section 903 requires a two-thirds vote unless a 1998 charter amendment lowered it.
The consequence of ignoring state nuance is an unenforceable merger. Ivy, GC of a New York acquirer, missed BCL 903 and had to redo the shareholder vote, slipping the close by 45 days.
Recap of Key Court Rulings That Shape S-4 Disclosure
Courts have shaped S-4 disclosure standards over four decades. In TSC Industries v. Northway, the Supreme Court defined materiality. In Basic v. Levinson, the Court adopted the probability-magnitude test for merger talks. In Virginia Bankshares v. Sandberg, the Court held that opinions can be actionable misstatements.
In Delaware, Corwin v. KKR established that fully informed, uncoerced shareholder votes restore business-judgment review. In Appel v. Berkman, the Delaware Supreme Court held that the chairman’s reasons for opposing a deal are material. The consequence of failing to disclose under these rulings is a Section 14(a) lawsuit and loss of Corwin cleansing.
FAQs
Is Form S-4 required for every stock-for-stock merger?
Yes. Any issuance of new securities to target shareholders requires registration under Section 5, unless a clean exemption like Section 3(a)(10) or a private placement under Rule 506 applies.
Can a private company be the registrant on Form S-4?
Yes. A private acquirer becoming public through the deal may file Form S-4, and it will become a reporting company under Section 15(d) once the form goes effective.
Do I need audited target financials before filing?
Yes. Rule 3-05 of Regulation S-X requires up to three years of audited target statements, depending on significance tests measured under Rule 1-02(w).
Does the JOBS Act let me submit my S-4 confidentially?
Yes. Emerging growth companies and many other filers may submit a draft S-4 confidentially under expanded SEC procedures, but must publicly file at least 15 days before solicitation.
Is a fairness opinion legally required in an S-4?
No. Federal law does not mandate a fairness opinion, but Delaware fiduciary duty case law and FINRA Rule 5150 make one a near-universal practice for public boards.
Can I incorporate my Form 10-K into the S-4 by reference?
Yes. Eligible registrants under General Instruction B may incorporate by reference Exchange Act filings, which sharply reduces drafting time and printing cost.
Do SPAC business combinations still get the PSLRA safe harbor for projections?
No. The SEC’s 2024 SPAC final rules eliminated the PSLRA safe harbor for de-SPAC projections, raising the litigation risk on forward-looking statements.
Is a separate Schedule 14A required when filing Form S-4?
No. When proxies are solicited, Item 18 of the S-4 incorporates Schedule 14A items, creating one combined joint proxy/prospectus document.
Can I use Form S-4 for an asset acquisition?
Yes. Form S-4 is available for any business combination as defined in Rule 145(a), including asset purchases paid with registered securities.
Does Form S-4 preempt state blue-sky review?
Yes. Securities registered on Form S-4 and listed on a national exchange are covered securities under Section 18 of the Securities Act, preempting state registration but not antifraud rules.
Is the filing fee refundable if the deal terminates?
No. SEC filing fees calculated under Rule 457 are not refundable, but unused fees can sometimes be offset against a future registration under Rule 457(p).
Do I have to file Rule 425 communications for every press release?
Yes. Any written communication about the deal made after the first public announcement must be filed on the date of first use under Rule 425.
Related reading